IGC Pharma (IGC) EBIT Margin (2010 - 2026)
IGC Pharma (IGC) posted EBIT Margin of -775.39% for FY2026, down 189.56 percentage points from -585.84% in FY2025.
Powered by 
Analysis
IGC Pharma (IGC) EBIT Margin (2010 - 2026) Analysis & Trends
Since FY2011, IGC Pharma has reported EBIT Margin for 16 years.
- Annual EBIT Margin shows a five-year change of +196.10 percentage points (FY2021 to FY2026).
- The FY2026 figure stands as the lowest annual EBIT Margin since FY2023.
- Business Quant data shows IGC's EBIT Margin at -585.84% in FY2025 (+142.64 pp), -728.48% in FY2024 (+541.67 pp), -1270.14% in FY2023 (+2616.00 pp) and -3886.15% in FY2022 (-2914.65 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | IGC Pharma | 26.67 Mn | 23.92 Mn | 55,000.00 | -775.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -775.39% |
| Sep 30, 2025 | -1,517.80% |
| Jun 30, 2025 | -580.79% |
| Mar 31, 2025 | -428.18% |
| Dec 31, 2024 | -730.74% |
| Sep 30, 2024 | -427.18% |
| Jun 30, 2024 | -880.88% |
| Mar 31, 2024 | -735.59% |
| Dec 31, 2023 | -1,469.61% |
| Sep 30, 2023 | -856.01% |
| Jun 30, 2023 | -385.41% |
| Mar 31, 2023 | -2,433.13% |
| Dec 31, 2022 | -686.14% |
| Sep 30, 2022 | -1,231.68% |
| Jun 30, 2022 | -1,321.70% |
| Mar 31, 2022 | -5,328.69% |
| Dec 31, 2021 | -1,679.58% |
| Sep 30, 2021 | -7,764.29% |
| Jun 30, 2021 | -2,849.35% |
| Mar 31, 2021 | -3,445.68% |
API Access
IGC Pharma EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();